Financhill
Sell
47

ASML Quote, Financials, Valuation and Earnings

Last price:
$706.01
Seasonality move :
11.64%
Day range:
$696.28 - $720.40
52-week range:
$645.45 - $1,110.09
Dividend yield:
0.96%
P/E ratio:
36.94x
P/S ratio:
9.76x
P/B ratio:
15.38x
Volume:
2.7M
Avg. volume:
1.8M
1-year change:
-3.28%
Market cap:
$277.5B
Revenue:
$29.8B
EPS (TTM):
$19.10
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $13.2B $16B $22B $22.3B $29.8B
Revenue Growth (YoY) 2.4% 20.64% 37.94% 1.4% 33.61%
 
Cost of Revenues $7.3B $8.2B $10.4B $11B $14.5B
Gross Profit $5.9B $7.8B $11.6B $11.3B $15.3B
Gross Profit Margin 44.67% 48.63% 52.71% 50.54% 51.3%
 
R&D Expenses $2.2B $2.5B $3B $3.4B $4.3B
Selling, General & Admin $582.7M $622.3M $858.5M $997.5M $1.2B
Other Inc / (Exp) -- -- $252.8M -- --
Operating Expenses $2.8B $3.1B $3.9B $4.4B $5.5B
Operating Income $3.1B $4.6B $7.7B $6.9B $9.8B
 
Net Interest Expenses $28M $39.9M $52.8M $47M --
EBT. Incl. Unusual Items $3.1B $4.6B $7.9B $6.8B $9.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $214.6M $629.8M $1.2B $1B $1.6B
Net Income to Company $2.9B $4.1B $7B $5.9B $8.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.9B $4.1B $7B $5.9B $8.5B
 
Basic EPS (Cont. Ops) $6.90 $9.70 $16.99 $14.91 $21.55
Diluted EPS (Cont. Ops) $6.88 $9.68 $16.97 $14.90 $21.55
Weighted Average Basic Share $420.8M $418.3M $409.8M $397.7M $393.8M
Weighted Average Diluted Share $421.6M $419.1M $410.4M $398M $394.1M
 
EBITDA $3.6B $5.2B $8.6B $7.5B $10.8B
EBIT $3.1B $4.6B $8B $6.9B $10B
 
Revenue (Reported) $13.2B $16B $22B $22.3B $29.8B
Operating Income (Reported) $3.1B $4.6B $7.7B $6.9B $9.8B
Operating Income (Adjusted) $3.1B $4.6B $8B $6.9B $10B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.6B $6.2B $5.8B $7.3B $8.2B
Revenue Growth (YoY) 39.38% 33.52% -5.81% 24.82% 13.04%
 
Cost of Revenues $2.4B $3B $2.8B $3.5B $4B
Gross Profit $2.2B $3.2B $3B $3.8B $4.2B
Gross Profit Margin 47.53% 51.73% 51.81% 51.88% 50.8%
 
R&D Expenses $624.5M $718.3M $825.4M $1.1B $1.2B
Selling, General & Admin $153.8M $215.6M $237.5M $313.4M $326.6M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $778.2M $933.9M $1.1B $1.4B $1.5B
Operating Income $1.4B $2.3B $2B $2.4B $2.7B
 
Net Interest Expenses $9.8M $12.4M $15.2M -- $879.8K
EBT. Incl. Unusual Items $1.4B $2.3B $1.9B $2.4B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $194.7M $319.4M $253.9M $374.2M $485.2M
Net Income to Company $1.3B $2B $1.6B $2.1B $2.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.2B $2.1B $1.7B $2.1B $2.3B
 
Basic EPS (Cont. Ops) $2.97 $5.03 $4.32 $5.24 $5.81
Diluted EPS (Cont. Ops) $2.96 $5.02 $4.32 $5.24 $5.81
Weighted Average Basic Share $418.4M $407.9M $396.2M $393.4M $393.2M
Weighted Average Diluted Share $419.2M $408.6M $396.6M $393.7M $393.6M
 
EBITDA $1.6B $2.4B $2.1B $2.6B $2.9B
EBIT $1.4B $2.3B $2B $2.4B $2.7B
 
Revenue (Reported) $4.6B $6.2B $5.8B $7.3B $8.2B
Operating Income (Reported) $1.4B $2.3B $2B $2.4B $2.7B
Operating Income (Adjusted) $1.4B $2.3B $2B $2.4B $2.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $15.5B $21.4B $21.3B $28.6B $28.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.1B $10.2B $10.4B $13.9B $13.9B
Gross Profit $7.3B $11.1B $10.9B $14.7B $14.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.4B $2.9B $3.3B $4.1B $4.6B
Selling, General & Admin $605.9M $806.3M $938.7M $1.2B $1.2B
Other Inc / (Exp) -- -- $244.4M -- --
Operating Expenses $3B $3.7B $4.2B $5.3B $5.8B
Operating Income $4.3B $7.4B $6.7B $9.4B $8.7B
 
Net Interest Expenses $35.5M $48.3M $58.2M -- --
EBT. Incl. Unusual Items $4.3B $7.4B $6.9B $9.4B $8.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $569.3M $1B $1B $1.5B $1.5B
Net Income to Company $3.9B $6.3B $6B $8.4B $7.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.8B $6.5B $6B $8.1B $7.5B
 
Basic EPS (Cont. Ops) $8.96 $15.79 $15.05 $20.64 $19.11
Diluted EPS (Cont. Ops) $8.94 $15.77 $15.04 $20.63 $19.10
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $4.8B $8B $7.2B $10.2B $9.9B
EBIT $4.3B $7.4B $6.7B $9.4B $9B
 
Revenue (Reported) $15.5B $21.4B $21.3B $28.6B $28.5B
Operating Income (Reported) $4.3B $7.4B $6.7B $9.4B $8.7B
Operating Income (Adjusted) $4.3B $7.4B $6.7B $9.4B $9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $11B $16.3B $15.6B $22B $20.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.8B $7.8B $7.8B $10.7B $10.1B
Gross Profit $5.2B $8.5B $7.8B $11.3B $10.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.8B $2.2B $2.5B $3.2B $3.5B
Selling, General & Admin $442.5M $625.6M $707.1M $899.4M $921.8M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.3B $2.9B $3.2B $4.1B $4.4B
Operating Income $2.9B $5.6B $4.6B $7.2B $6.2B
 
Net Interest Expenses $30.2M $38.8M $44.2M -- $13.7M
EBT. Incl. Unusual Items $2.9B $5.6B $4.6B $7.3B $6.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $431.5M $843M $644.5M $1.1B $1B
Net Income to Company $2.6B $4.8B $3.8B $6.3B $5.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.5B $4.9B $4B $6.3B $5.3B
 
Basic EPS (Cont. Ops) $5.97 $11.94 $10.03 $15.94 $13.50
Diluted EPS (Cont. Ops) $5.96 $11.92 $10.03 $15.93 $13.50
Weighted Average Basic Share $1.3B $1.2B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.3B $1.2B $1.2B $1.2B $1.2B
 
EBITDA $3.3B $6.1B $5B $7.8B $6.9B
EBIT $2.9B $5.6B $4.6B $7.2B $6.2B
 
Revenue (Reported) $11B $16.3B $15.6B $22B $20.7B
Operating Income (Reported) $2.9B $5.6B $4.6B $7.2B $6.2B
Operating Income (Adjusted) $2.9B $5.6B $4.6B $7.2B $6.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $4B $7.4B $7.9B $7.8B $7.7B
Short Term Investments $1.3B $1.6B $722.9M $115.5M $6M
Accounts Receivable, Net $2B $1.6B $3.4B $5.7B $4.8B
Inventory $4.3B $5.6B $5.9B $7.7B $9.8B
Prepaid Expenses $658.3M $669.7M $750.4M $1.2B $1.3B
Other Current Assets $146.9M $113.9M $168.5M $285.7M $102.2M
Total Current Assets $13.6B $19.6B $20.6B $24.7B $27B
 
Property Plant And Equipment $2.6B $3.5B $3.6B $4.4B $6.4B
Long-Term Investments $933.1M $1B $1B $990.5M $1B
Goodwill $5.1B $5.7B $5.2B $4.9B $5.1B
Other Intangibles $1.2B $1.3B $1.1B $903.4M $819.9M
Other Long-Term Assets $21.5M $18.3M $17M $17.1M $15M
Total Assets $25.3B $33.5B $34.2B $38.9B $44.2B
 
Accounts Payable $1.2B $1.7B $2.4B $2.8B $2.6B
Accrued Expenses $1.2B $1.4B $1.6B $2B $2.4B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5.3B $8.1B $13.9B $19.3B $18B
 
Long-Term Debt $3.5B $5.7B $4.6B $3.8B $5.1B
Capital Leases -- -- -- -- --
Total Liabilities $11.2B $16.5B $22.7B $29.5B $29.3B
 
Common Stock $42.8M $46.2M $41.3M $38.9M $39.8M
Other Common Equity Adj $311.2M $220.7M $377.6M $459.3M $381.4M
Common Equity $14.1B $17.1B $11.5B $9.4B $14.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $14.1B $17.1B $11.5B $9.4B $14.9B
 
Total Liabilities and Equity $25.3B $33.5B $34.2B $38.9B $44.2B
Cash and Short Terms $5.3B $9B $8.6B $7.9B $7.7B
Total Debt $3.5B $5.8B $5.2B $4.6B $5.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $4.1B $5B $3.1B $5.3B $5.6B
Short Term Investments $1B $158.9M $206.4M $5.7M $5.8M
Accounts Receivable, Net $2.9B $3.9B $5.7B $4.1B $5.8B
Inventory $5.4B $5.7B $6.8B $8.9B $12.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $907.2M $1.2B $1.6B $2B $2B
Total Current Assets $17.1B $18.2B $19.4B $22.9B $27.8B
 
Property Plant And Equipment $2.9B $3.4B $3.7B $5.7B $7.4B
Long-Term Investments $1.1B $1.1B $981.6M $1.2B $1.2B
Goodwill $5.3B $5.3B $4.5B $4.9B $5.1B
Other Intangibles $1.2B $1.1B $855.2M $800.9M $729.2M
Other Long-Term Assets $1.1B $1.3B $732.4M $909.5M $819.2M
Total Assets $29.9B $31.7B $32.2B $39.7B $46.6B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- $10.6B $15.4B $17.3B $17.9B
Total Current Liabilities $5.9B $10.6B $15.4B $17.3B $17.9B
 
Long-Term Debt $5.4B $4.8B $3.4B $4.8B $5.2B
Capital Leases -- -- -- -- --
Total Liabilities $13.8B $18.3B $24.4B $27B $28.6B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $16.1B $13.3B $7.8B $12.7B $18B
 
Total Liabilities and Equity $29.9B $31.7B $32.2B $39.7B $46.6B
Cash and Short Terms $5.2B $5.2B $3.3B $5.3B $5.6B
Total Debt $5.4B $4.8B $3.4B $4.8B $5.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.9B $4.1B $7B $5.9B $8.5B
Depreciation & Amoritzation $502.1M $560.5M $557.3M $615.5M $800.9M
Stock-Based Compensation $83.5M $61.6M $139M $72.7M $145.9M
Change in Accounts Receivable -$392.2M -$705.7M -$1.4B -$2.2B $943.3M
Change in Inventories -$453.1M -$807.1M -$571.7M -$2.2B -$1.8B
Cash From Operations $3.7B $5.3B $12.8B $9B $5.9B
 
Capital Expenditures $991.8M $1.1B $1.1B $1.4B $2.4B
Cash Acquisitions -- -$254.4M $389.3M -- -$36.4M
Cash From Investing -$1.3B -$1.5B -$85.2M -$1.1B -$2.9B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.2B -$1.6B -$2.7B -$2.5B
Special Dividend Paid
Long-Term Debt Issued -- $1.7B -- $522.7M $1.1B
Long-Term Debt Repaid -$4.3M -$3.8M -$14.3M -$544.4M -$815M
Repurchase of Common Stock -$459M -$1.4B -$10.1B -$4.9B -$1.1B
Other Financing Activities -- -- -- -- --
Cash From Financing -$1.9B -$859.9M -$11.7B -$7.5B -$3.3B
 
Beginning Cash (CF) $3.5B $4B $7.2B $7.3B $7.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $455.2M $2.9B $1B $337M -$270.4M
Ending Cash (CF) $4B $6.9B $8.2B $7.7B $7.6B
 
Levered Free Cash Flow $2.7B $4.1B $11.7B $7.6B $3.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.3B $2B $1.6B $2.1B $2.3B
Depreciation & Amoritzation $159.2M $131M $123.7M $191.3M $269.4M
Stock-Based Compensation $28M $38.8M $21.2M $45.1M $60.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $207.5M $2.1B $1.1B $1.2B $1.1B
 
Capital Expenditures $291.4M $230.1M $338.7M $553.6M $479.5M
Cash Acquisitions -- -$337K -- -$30.1M --
Cash From Investing -$210.4M -$347.5M -$503.6M -$1.2B -$263.2M
 
Dividends Paid (Ex Special Dividend) -$38.5M $16.7M -$462.1M -$619.1M -$684.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $101.2M -- -$28.6M -$1.6M --
Long-Term Debt Repaid -$1.2M -$2.9M $28.5M -$817M -$790.6K
Repurchase of Common Stock -$34.6M -$2.7B -$910.1M -$119.5M -$11.5M
Other Financing Activities -- -- -- -- --
Cash From Financing $40.5M -$2.7B -$1.4B -$1.5B -$660.6M
 
Beginning Cash (CF) $3.9B $6.3B $4.4B $6.9B $5.2B
Foreign Exchange Rate Adjustment -$2M $2.4M $8.4M $3.6M -$4.7M
Additions / Reductions $37.6M -$1B -$794M -$1.5B $136.4M
Ending Cash (CF) $4.1B $5.1B $3.2B $5.4B $5.5B
 
Levered Free Cash Flow -$83.9M $1.8B $725.7M $672.8M $580.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.9B $6.3B $6B $8.4B $7.5B
Depreciation & Amoritzation $567.4M $542.1M $551.7M $786.7M $971.6M
Stock-Based Compensation $88.8M $104.8M $88.2M $125.9M $176M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $4B $10.6B $10.8B $8.2B $5.2B
 
Capital Expenditures $1.2B $1.1B $1.2B $2.3B $2.2B
Cash Acquisitions -- -$239.2M $374.1M -$30.1M -$6.3M
Cash From Investing -$1.6B -$604.6M -$1.2B -$2.7B -$2.2B
 
Dividends Paid (Ex Special Dividend) -$1.2B -$1.3B -$2.9B -$2.6B -$2.6B
Special Dividend Paid
Long-Term Debt Issued $1.7B -- $499.3M $1.1B -$6.2M
Long-Term Debt Repaid -$4.1M -$11.8M -$522.4M -$844.6M $2.7M
Repurchase of Common Stock -$809.6M -$7.8B -$7.4B -$1.6B -$543.7M
Other Financing Activities -- -- -- -- --
Cash From Financing -$193.5M -$9.1B -$10.3B -$3.9B -$3.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.2B $835.8M -$751.4M $1.7B -$4.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.8B $9.5B $9.6B $6B $3.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.6B $4.8B $3.8B $6.3B $5.4B
Depreciation & Amoritzation $427.3M $408.9M $403.4M $574.6M $745.2M
Stock-Based Compensation $55.8M $99M $48.3M $101.5M $131.5M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$50.1M $5.2B $3.2B $2.4B $1.8B
 
Capital Expenditures $813.6M $766M $859.7M $1.7B $1.5B
Cash Acquisitions -- $15.2M -- -$30.1M --
Cash From Investing -$463.2M $476.5M -$669.8M -$2.3B -$1.5B
 
Dividends Paid (Ex Special Dividend) -$660.5M -$753.5M -$2B -$1.9B -$2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.7B -- $499.3M $1.1B --
Long-Term Debt Repaid -$3M -$11.1M -$519.2M -$819.4M -$1.8M
Repurchase of Common Stock -$593.5M -$7B -$4.3B -$1.1B -$549.9M
Other Financing Activities -- -- -- -- --
Cash From Financing $516.2M -$7.7B -$6.3B -$2.7B -$2.5B
 
Beginning Cash (CF) $14.1B $17.4B $17B $21.9B $18.3B
Foreign Exchange Rate Adjustment -$3.9M $1.3M $10M -$8.7M -$6.3M
Additions / Reductions $2.9M -$2B -$3.8B -$2.5B -$2.2B
Ending Cash (CF) $11.6B $15.3B $12.4B $19.5B $16.2B
 
Levered Free Cash Flow -$863.6M $4.5B $2.3B $710.4M $268.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock